UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
18.79
-0.45 (-2.34%)
Aug 29, 2025, 10:56 AM - Market open

UroGen Pharma Stock Forecast

Stock Price Forecast

The 8 analysts that cover UroGen Pharma stock have a consensus rating of "Strong Buy" and an average price target of $28.5, which forecasts a 51.68% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $47.

Price Target: $28.5 (+51.68%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$3.00$28.5$31$47
Change-84.03%+51.68%+64.98%+150.13%

Analyst Ratings

The average analyst rating for UroGen Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy555554
Buy111223
Hold012111
Sell000000
Strong Sell000000
Total678888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Initiates
$36
BuyInitiates$36+91.59%Aug 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$50$40
Strong BuyMaintains$50$40+112.88%Aug 11, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$25
Strong BuyMaintains$25+33.05%Aug 7, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$25
Strong BuyMaintains$25+33.05%Aug 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong BuyReiterates$50+166.10%Jul 8, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
122.58M
from 90.40M
Increased by 35.60%
Revenue Next Year
281.37M
from 122.58M
Increased by 129.54%
EPS This Year
-2.88
from -2.96
EPS Next Year
-0.77
from -2.88
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
11.80M48.04M64.36M82.71M90.40M122.58M281.37M
Revenue Growth
65,450.00%307.17%33.96%28.52%9.29%35.60%129.54%
EPS
-5.90-4.96-4.81-3.55-2.96-2.88-0.77
EPS Growth
-------
Forward PE
-------
No. Analysts
-----99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High142.6M411.1M
Avg122.6M281.4M
Low103.9M220.0M

Revenue Growth

Revenue Growth20252026202720282029
High
57.7%
235.3%
Avg
35.6%
129.5%
Low
14.9%
79.5%

EPS Forecast

EPS20252026202720282029
High-0.972.14
Avg-2.88-0.77
Low-3.30-3.03

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.